These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Schizophrenia and cognition: long-standing and current issues]. Azorin JM; Da Fonseca D; Fakra E Encephale; 2011 Dec; 37 Suppl 2():S93-4. PubMed ID: 22212848 [No Abstract] [Full Text] [Related]
5. [Schizophrenia]. Schimmelmann BG; Dittmann R Z Kinder Jugendpsychiatr Psychother; 2009 Jul; 37(4):335-40. PubMed ID: 20306802 [No Abstract] [Full Text] [Related]
6. Important steps in the development of cognitive-enhancing drugs in schizophrenia. Buchanan RW Am J Psychiatry; 2006 Nov; 163(11):1867-9. PubMed ID: 17074932 [No Abstract] [Full Text] [Related]
7. Thinking and schizophrenia: challenges and opportunities. Tan HY Ann Acad Med Singap; 2013 May; 42(5):213-5. PubMed ID: 23771107 [No Abstract] [Full Text] [Related]
8. Familial and sporadic schizophrenia: a symptomatic, prognostic, and EEG comparison. Kendler KS; Hays P Am J Psychiatry; 1982 Dec; 139(12):1557-62. PubMed ID: 6128925 [TBL] [Abstract][Full Text] [Related]
9. Of rats and schizophrenia. Boksa P J Psychiatry Neurosci; 2007 Jan; 32(1):8-10. PubMed ID: 17245468 [No Abstract] [Full Text] [Related]
11. Polygenic Risk Scores in Clinical Schizophrenia Research. Weinberger DR Am J Psychiatry; 2019 Jan; 176(1):3-4. PubMed ID: 30848945 [No Abstract] [Full Text] [Related]
12. Cognitive function in schizophrenia: conflicting findings and future directions. Moustafa AA; Garami JK; Mahlberg J; Golembieski J; Keri S; Misiak B; Frydecka D Rev Neurosci; 2016 Jun; 27(4):435-48. PubMed ID: 26756090 [TBL] [Abstract][Full Text] [Related]
13. Cognitive improvement in response to antipsychotic drugs: neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. Heinrichs RW Arch Gen Psychiatry; 2007 Jun; 64(6):631-2. PubMed ID: 17548745 [No Abstract] [Full Text] [Related]
14. Treatment of cognitive dysfunction in schizophrenia. Peuskens J; Demily C; Thibaut F Clin Ther; 2005; 27 Suppl A():S25-37. PubMed ID: 16198199 [TBL] [Abstract][Full Text] [Related]
15. Social cognition and visual perception in schizophrenia inpatients treated with first-and second-generation antipsychotic drugs. Kucharska-Pietura K; Mortimer A; Tylec A; Czernikiewicz A Clin Schizophr Relat Psychoses; 2012 Apr; 6(1):14-20. PubMed ID: 22453865 [TBL] [Abstract][Full Text] [Related]
17. Researchers focus on recovery in schizophrenia. Friedrich MJ JAMA; 2014 Jul; 312(1):16-8. PubMed ID: 24942273 [No Abstract] [Full Text] [Related]
18. Theories of the schizophrenic performance deficit: an integration theory synthesis. Magaro PA Prog Exp Pers Res; 1974; 7():149-208. PubMed ID: 4614322 [No Abstract] [Full Text] [Related]
19. The MATRICS consensus cognitive battery: what we know 6 years later. Green MF; Harris JG; Nuechterlein KH Am J Psychiatry; 2014 Nov; 171(11):1151-4. PubMed ID: 25756630 [No Abstract] [Full Text] [Related]
20. [Childhood and adolescent-onset schizophrenia: new information and definitions]. Amitai M; Sever Y; Weizman A; Zalsman G Harefuah; 2012 Sep; 151(9):550-3, 554. PubMed ID: 23367752 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]